GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Scaled Net Operating Assets

Hisamitsu Pharmaceutical Co (TSE:4530) Scaled Net Operating Assets : 0.43 (As of Nov. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hisamitsu Pharmaceutical Co's operating assets for the quarter that ended in Nov. 2023 was 円210,997 Mil. Hisamitsu Pharmaceutical Co's operating liabilities for the quarter that ended in Nov. 2023 was 円62,251 Mil. Hisamitsu Pharmaceutical Co's Total Assets for the quarter that ended in Aug. 2023 was 円344,300 Mil. Therefore, Hisamitsu Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Nov. 2023 was 0.43.


Hisamitsu Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Scaled Net Operating Assets Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.39 0.38 0.41 0.46

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.40 0.42 0.43 0.43

Competitive Comparison of Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets falls into.



Hisamitsu Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Feb. 2024 )
=(Operating Assets (A: Feb. 2024 )-Operating Liabilities (A: Feb. 2024 ))/Total Assets (A: Feb. 2023 )
=(203458-59603)/313917
=0.46

where

Operating Assets(A: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=328779 - 125321
=203458

Operating Liabilities(A: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=61703 - 679 - 1421
=59603

Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Nov. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Nov. 2023 )
=(Operating Assets (Q: Nov. 2023 )-Operating Liabilities (Q: Nov. 2023 ))/Total Assets (Q: Aug. 2023 )
=(210997-62251)/344300
=0.43

where

Operating Assets(Q: Nov. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=334909 - 123912
=210997

Operating Liabilities(Q: Nov. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=63417 - 95 - 1071
=62251

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines